Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 332

Similar articles for PubMed (Select 23300270)

1.

Prophylaxis against venous thromboembolism in hospitalized medically ill patients.

Pendergraft T, Liu X, Edelsberg J, Phatak H, Vera-Llonch M, Liu LZ, Oster G.

Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):75-82. doi: 10.1161/CIRCOUTCOMES.112.965939. Epub 2013 Jan 8.

2.

Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review.

Rahim SA, Panju A, Pai M, Ginsberg J.

Thromb Res. 2003;111(4-5):215-9.

PMID:
14693166
3.

Venous thromboembolism prophylaxis and clinical consequences in medically ill patients.

Baser O, Liu X, Phatak H, Wang L, Mardekian J, Kawabata H, Petersel D, Hamilton M, Ramacciotti E.

Am J Ther. 2013 Mar-Apr;20(2):132-42. doi: 10.1097/MJT.0b013e31826910dd.

PMID:
23466619
4.

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH; American College of Chest Physicians.

Chest. 2012 Feb;141(2 Suppl):e195S-226S. doi: 10.1378/chest.11-2296.

5.

Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.

Kociol RD, Hammill BG, Hernandez AF, Klaskala W, Mills RM, Curtis LH, Fonarow GC.

Clin Cardiol. 2011 Nov;34(11):682-8. doi: 10.1002/clc.20986. Epub 2011 Nov 6.

PMID:
22057910
6.

Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.

Robertson MS, Nichol AD, Higgins AM, Bailey MJ, Presneill JJ, Cooper DJ, Webb SA, McArthur C, MacIsaac CM; VTE Point Prevalence Investigators for the Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Resusc. 2010 Mar;12(1):9-15.

PMID:
20196708
7.

Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.

Reeves D, Liu CY.

J Oncol Pharm Pract. 2010 Mar;16(1):27-31. doi: 10.1177/1078155209104379. Epub 2009 Apr 28.

PMID:
19401307
8.

Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations.

Friedman AM, Ananth CV, Prendergast E, Chauhan SP, D'Alton ME, Wright JD.

Am J Obstet Gynecol. 2015 Feb;212(2):221.e1-12. doi: 10.1016/j.ajog.2014.09.017. Epub 2014 Sep 21.

PMID:
25240092
9.

Asian venous thromboembolism guidelines: prevention of venous thromboembolism.

Liew NC, Chang YH, Choi G, Chu PH, Gao X, Gibbs H, Ho CO, Ibrahim H, Kim TK, Kritpracha B, Lee LH, Lee L, Lee WY, Li YJ, Nicolaides AN, Oh D, Pratama D, Ramakrishnan N, Robless PA, Villarama-Alemany G, Wong R; Asian Venous Thrombosis Forum.

Int Angiol. 2012 Dec;31(6):501-16. Review.

PMID:
23222928
10.

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM; American College of Chest Physicians.

Chest. 2012 Feb;141(2 Suppl):e227S-77S. doi: 10.1378/chest.11-2297. Erratum in: Chest. 2012 May;141(5):1369.

11.

Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, Spyropoulos AC, Merli GJ, Zotz RB, Bergmann JF, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, Fitzgerald G, Anderson FA Jr; IMPROVE Investigators.

Chest. 2007 Sep;132(3):936-45. Epub 2007 Jun 15.

PMID:
17573514
12.

Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.

Brown A.

Am J Health Syst Pharm. 2012 Mar 15;69(6):469-81. doi: 10.2146/ajhp110187. Review.

PMID:
22382477
14.

Prevention of venous thromboembolism in the hospitalized medical patient.

Jaffer AK, Amin AN, Brotman DJ, Deitelzweig SB, McKean SC, Spyropoulos AC.

Cleve Clin J Med. 2008 Apr;75 Suppl 3:S7-16. Review.

PMID:
18494223
15.
16.

Procedure-specific venous thromboembolism prophylaxis: a paradigm from colectomy surgery.

Henke PK, Arya S, Pannucci C, Kubus J, Hendren S, Engelsbe M, Campbell D.

Surgery. 2012 Oct;152(4):528-34; discussion 534-6. doi: 10.1016/j.surg.2012.07.012.

PMID:
23021132
17.

Venous thromboembolism prophylaxis in hospitalized heart failure patients.

Jois-Bilowich P, Michota F, Bartholomew JR, Glauser J, Diercks D, Weber J, Fonarow GC, Emerman CL, Peacock WF 4th; Adhere Scientific Advisory Committee and Investigators.

J Card Fail. 2008 Mar;14(2):127-32. doi: 10.1016/j.cardfail.2007.10.017.

PMID:
18325459
18.

Identification of residual risk factors for the development of venous thromboembolism in medical inpatients receiving subcutaneous heparin therapy for prophylaxis.

Kato S, Shimada YJ, Friedmann P, Kashan G, Husk G, Bergmann SR.

Coron Artery Dis. 2012 Jun;23(4):294-7. doi: 10.1097/MCA.0b013e328352e510.

PMID:
22421548
19.

Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.

Stinnett JM, Pendleton R, Skordos L, Wheeler M, Rodgers GM.

Am J Hematol. 2005 Mar;78(3):167-72.

PMID:
15726600
20.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk